Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134648) titled 'Prediction of sentinel lymph node metastasis and high nodal burden based on hematological parameters and clinical characteristics in clinically node-negative early invasive breast cancer' on Oct. 19.
Study Type: Observational study
Study Design:
Factorial
Primary Sponsor: The First Affiliated Hospital of Zhengzhou University
Condition:
cN0 early-stage invasive breast cancer
Intervention:
SLN-positive group?SLN-negative group
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-28
Target Sample Size: SLN-positive group?SLN-negative group;High lymph node burden?Low lymph node bur...